Elevance Health Q3 2026 net income rises 13% year over year to $1.34 billion

Bitget2026/10/21 10:04

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Elevance Health’s third-quarter 2026 diluted earnings rose 18% year over year to $6.27 per share.
Operating revenue increased year over year to $50.44 billion, supported by higher premium yields, CarelonRx product revenue and service fees.
Health Benefits operating gain fell 27% year over year to $436 million, reflecting targeted investments supporting its long-term operating model.
The full-year 2026 outlook calls for diluted earnings of at least $22 per share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20261020437030) on October 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Elevance Health Q3 2026 net income rises 13% year over year to $1.34 billion

You may also like

Crypto prices